Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock
Jaime Hernández-Montfort(Baylor Scott & White Health), Navin K. Kapur(Tufts University), Maya Guglin(Indiana University Health), Claudius Mahr(University of Washington Medical Center), A.R. Garan(Beth Israel Deaconess Medical Center), Shashank S. Sinha(Inova Fairfax Hospital), Michael T. Yin(Columbia University Irving Medical Center), Rachna Kataria(Massachusetts General Hospital), Katherine Thayer(Tufts Medical Center), Fatou Dieng(Tufts Medical Center), Daniel Burkhoff(Witten/Herdecke University), Song Li(University of Pittsburgh), Wissam Khalife(The University of Texas Medical Branch at Galveston), Andrew Schwartzman(Maine Medical Center), Mohit Pahuja, Manreet Kanwar(Allegheny Health Network), Esther Vorovich(Northwestern Medicine), Paulina Baca(Tufts Medical Center), Jacob Abraham(Providence College), Detlef Wencker(Baylor Scott & White Health), Evan H. Whitehead(Massachusetts General Hospital), Sandeep Nathan(University of Chicago), Vanessa Blumer(Duke Medical Center), Ju Kim(Jeonbuk National University), Gavin Hickey(University of Pittsburgh Medical Center), Neil Harwani(Tufts Medical Center), Yijing Zhang(Tongji University), Borui Li(Tufts Medical Center), Shelley Hall
Cited by 88
Related Papers
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283
Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications
|Intensive Care Medicine|2021|252
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
|Clinical Gastroenterology and Hepatology|2021|221
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
|Nature Communications|2021|194